HealthQuill AbbVie
The US Food and Drug Administration has approved Ionis Pharmaceuticalsā€™ drug to treat a rare and life-threatening genetic disease known as familial chylomicronemia syndrome (FCS), according to a statement.
Drugs Pharma

AbbVie’s drug-resistant abdominal infection medicine gets US nod

HQ Team February 10, 2025: The U.S. Food and Drug Administration (FDA) has approved Emblaveo, a new antibiotic combination of aztreonam and avibactam,.

Read More
Supernus Pharmaceuticals Incā€™s injection for treating people with advanced Parkinsonā€™s disease got a green light from the US regulator after two earlier rejections.
Drugs Health Medical

Supernusā€™ injection to treat advanced Parkinsonā€™s gets US regulatorā€™s nod

Supernus Pharmaceuticals Incā€™s injection for treating people with advanced Parkinsonā€™s disease got a green light from the US regulator after two earlier rejections.

Read More
The European Commission has granted Pfizer Inc., marketing authorisation for a drug to treat adult patients with intra-abdominal infections, hospital-acquired pneumonia and complex urinary tract infections.
Drugs Health Pharma

EC marketing nod for Pfizer drug to fight antimicrobial resistance

HQ Team April 22, 2024: The European Commission has granted Pfizer Inc., marketing authorisation for a drug to treat adult patients with intra-abdominal.

Read More